ZA945416B - Method of inhibiting the production of infectious human immunodeficiency viruses (HIV) in HIV seropositive humans. - Google Patents

Method of inhibiting the production of infectious human immunodeficiency viruses (HIV) in HIV seropositive humans.

Info

Publication number
ZA945416B
ZA945416B ZA945416A ZA945416A ZA945416B ZA 945416 B ZA945416 B ZA 945416B ZA 945416 A ZA945416 A ZA 945416A ZA 945416 A ZA945416 A ZA 945416A ZA 945416 B ZA945416 B ZA 945416B
Authority
ZA
South Africa
Prior art keywords
hiv
inhibiting
production
human immunodeficiency
immunodeficiency viruses
Prior art date
Application number
ZA945416A
Other languages
English (en)
Inventor
Alison Mary Badger
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of ZA945416B publication Critical patent/ZA945416B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA945416A 1993-07-23 1994-07-22 Method of inhibiting the production of infectious human immunodeficiency viruses (HIV) in HIV seropositive humans. ZA945416B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939315306A GB9315306D0 (en) 1993-07-23 1993-07-23 Methods

Publications (1)

Publication Number Publication Date
ZA945416B true ZA945416B (en) 1995-05-10

Family

ID=10739328

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA945416A ZA945416B (en) 1993-07-23 1994-07-22 Method of inhibiting the production of infectious human immunodeficiency viruses (HIV) in HIV seropositive humans.

Country Status (8)

Country Link
EP (1) EP0713391A4 (fr)
CN (1) CN1130870A (fr)
AU (1) AU7370894A (fr)
CA (1) CA2167841A1 (fr)
GB (1) GB9315306D0 (fr)
NZ (1) NZ269990A (fr)
WO (1) WO1995003041A1 (fr)
ZA (1) ZA945416B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9315340D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
GB9315351D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
BR9601909A (pt) * 1995-07-13 1999-10-13 Smithkline Beecham Corp N,n-dietil-8,8-dipropil-2-azaspiro(4,5)decano-2-propan amina dimaleato
HUP0003908A3 (en) * 1996-05-17 2001-04-28 Anormed Inc Langley Use of substituted azaspirane in the manufacture of a medicament for use in treating asthma
TW574036B (en) 1998-09-11 2004-02-01 Elan Pharm Inc Stable liquid compositions of botulinum toxin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963557A (en) * 1987-09-28 1990-10-16 Smithkline Beecham Corporation Immunomodulatory azaspiranes
ZA921120B (en) * 1991-02-19 1993-01-27 Smithkline Beecham Corp Cytokine inhibitors
GB9201804D0 (en) * 1992-01-28 1992-03-11 Smithkline Beecham Corp Methods
GB9201803D0 (en) * 1992-01-28 1992-03-11 Smithkline Beecham Corp Methods
GB9315340D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
GB9315271D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
GB9315351D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods

Also Published As

Publication number Publication date
NZ269990A (en) 1999-07-29
EP0713391A1 (fr) 1996-05-29
GB9315306D0 (en) 1993-09-08
AU7370894A (en) 1995-02-20
CA2167841A1 (fr) 1995-02-02
EP0713391A4 (fr) 1998-09-09
WO1995003041A1 (fr) 1995-02-02
CN1130870A (zh) 1996-09-11

Similar Documents

Publication Publication Date Title
EP0676954A4 (fr) Leurre de virus de l'immunodeficience humaine.
FI906212A0 (fi) Inhibitorer foer hiv-proteas, vilka aer anvaendbara vid av aids.
WO1993017651A3 (fr) Analogues nucleosidiques antiviraux, leur fabrication et leur utilisation
AU7007491A (en) Cdna corresponding to the genome of negative-strand rna viruses, and process for the production of infectious negative-strand rna viruses
GR3035521T3 (en) Modified plant viruses as vectors.
EP0334368A3 (fr) Préparation de nucléosides 2',3'-didéoxy-2',3'-didéhydro
ZA936592B (en) Nutrition for persons infected with human immunodeficiency virus
KR970702919A (ko) 재조합형의 인간면역부전바이러스 담체 및 그 제조방법(Recombinant Human Immunodeficiency Virus Vector and Process for Producing the same)
EP0631506A4 (fr) Vaccins comprenant les proteines d'enveloppe du virus de l'immunodeficience humaine de type 1 selectivement deglycosylees.
NZ307494A (en) Lymphokine capable of inhibiting immunodeficiency viruses
ZA943917B (en) Virus resistant plants
HUT64395A (en) Genes being resistant against viruses and herbicides, method for their production and application
ZA945416B (en) Method of inhibiting the production of infectious human immunodeficiency viruses (HIV) in HIV seropositive humans.
HUT69056A (en) Cyclic-acetals, process for their preparation and their use as herbicides
AU4472801A (en) Inactivated japanese B encephalitis vaccine and process for producing the same
ZA945418B (en) Method of inhibiting the replication of human immunodeficiency viruses (HIV) in HIV seropositive humans.
IL110967A0 (en) Substituted tetronic acids useful for treating hiv and other retroviruses
ZA945417B (en) Method of inhibiting cellular entry of human immunodeficiency viruses NHIV) in HIV seropositive humans.
WO1996001110A3 (fr) Triple combinaison anti-vih
AU4569393A (en) Anti-feline immunodeficiency virus (fiv) vaccines
AU6877991A (en) A method of inactivating human immunodeficiency virus
EP0674657A4 (fr) Gp41 mutants et leur utilisation comme agents therapeutiques contre le vih.
AU6130194A (en) 1,2-dithiole-3-thiones for the treatment of reverse transcriptase-dependent viral infections
WO1993014760A3 (fr) Procedes
AU5000796A (en) Process for the deactivation of hiv and other viruses